… P2Y 12 antagonist monotherapy to specific patient subgroups is currently hampered by the
… , we randomized patients with PCI to receive either TIC or DAPT with ticagrelor and aspirin (…

… (6.7%) treated with aspirin (hazard ratio, 0.87; 95% CI, 0.76 to 1.00). Major bleeding
occurred in 0.5% of patients treated with ticagrelor and in 0.6% of patients treated with aspirin, …

… -of-function allele to either ticagrelor and aspirin or clopidogrel and aspirin. In the future, …
comparison between the efficacy and safety of clopidogrel and aspirin vs ticagrelor and aspirin …

… A randomized controlled trial comparing ticagrelor vs. aspirin monotherapy for 12 months
in patients after coronary artery bypass grafting (CABG). *) CABG - coronary artery bypass …

… In the comparisons according to clinical presentation, patients with STEMI were younger and
had a lower prevalence of comorbid conditions, history of PCI, multivessel intervention, and …

… 016 patients (5523 ticagrelor-aspirin and 5493 aspirin), a major ischemic event occurred in
294 patients (5.3%) in the ticagrelor-aspirin … outcome measures and comparing relative risks …

… in 303 patients (5.5%) in the ticagrelor–aspirin group and in 362 patients (6.6%) in the aspirin
… Ischemic stroke occurred in 276 patients (5.0%) in the ticagrelor–aspirin group and in 345 …

… of ticagrelor alone as compared with ticagrelor plus aspirin with regard to clinically relevant
bleeding among patients … After 3 months of treatment with ticagrelor plus aspirin, patients who …

… because ticagrelor monotherapy rather than aspirin monotherapy … , when 1967 patients (64%)
were enrolled and 795 patients (26%… Comparisons between the group receiving ticagrelor …

… randomization (intention-to-treat population) comparing ticagrelor plus placebo versus
ticagrelor plus aspirin in patients who underwent complex and noncomplex PCI. The interaction p …